East Asia & Pacific (IDA & IBRD countries) vs Mongolia: Immunization, Hib3
Immunization, Hib3 over time
- East Asia & Pacific (IDA & IBRD countries)
- Mongolia
How they compare
Mongolia currently reports 96.0% against 40.1% in East Asia & Pacific (IDA & IBRD countries), a difference of 55.9%.
That makes Mongolia's figure about 2.4 times East Asia & Pacific (IDA & IBRD countries)'s.
Across all 20 years both countries report, Mongolia has been ahead every year.
East Asia & Pacific (IDA & IBRD countries) ranks 43rd and Mongolia ranks 46th of 43 groups.
Mongolia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | East Asia & Pacific (IDA & IBRD countries) | Mongolia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.0% | 71.0% | 69.0% | Mongolia |
| 2010s | 23.0% | 98.5% | 75.5% | Mongolia |
| 2020s | 36.7% | 95.6% | 58.9% | Mongolia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, East Asia & Pacific (IDA & IBRD countries) or Mongolia?
- Mongolia, at 96.0% against 40.1% in East Asia & Pacific (IDA & IBRD countries) as of 2024.
- What is the difference in immunization, hib3 between East Asia & Pacific (IDA & IBRD countries) and Mongolia?
- 55.9%, with Mongolia ahead.
- How many years of comparable data are there for East Asia & Pacific (IDA & IBRD countries) and Mongolia?
- 20 years are reported by both, from 2005 to 2024.
- How do East Asia & Pacific (IDA & IBRD countries) and Mongolia rank globally for immunization, hib3?
- East Asia & Pacific (IDA & IBRD countries) ranks 43rd and Mongolia ranks 46th of 43 groups.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.